Style | Citing Format |
---|---|
MLA | Esmaealzadeh N, et al.. "The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms." Inflammopharmacology, vol. 32, no. 4, 2024, pp. 2125-2151. |
APA | Esmaealzadeh N, Miri MS, Mavaddat H, Peyrovinasab A, Ghasemi Zargar S, Sirous Kabiri S, Razavi SM, Abdolghaffari AH (2024). The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms. Inflammopharmacology, 32(4), 2125-2151. |
Chicago | Esmaealzadeh N, Miri MS, Mavaddat H, Peyrovinasab A, Ghasemi Zargar S, Sirous Kabiri S, Razavi SM, Abdolghaffari AH. "The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms." Inflammopharmacology 32, no. 4 (2024): 2125-2151. |
Harvard | Esmaealzadeh N et al. (2024) 'The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms', Inflammopharmacology, 32(4), pp. 2125-2151. |
Vancouver | Esmaealzadeh N, Miri MS, Mavaddat H, Peyrovinasab A, Ghasemi Zargar S, Sirous Kabiri S, et al.. The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms. Inflammopharmacology. 2024;32(4):2125-2151. |
BibTex | @article{ author = {Esmaealzadeh N and Miri MS and Mavaddat H and Peyrovinasab A and Ghasemi Zargar S and Sirous Kabiri S and Razavi SM and Abdolghaffari AH}, title = {The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms}, journal = {Inflammopharmacology}, volume = {32}, number = {4}, pages = {2125-2151}, year = {2024} } |
RIS | TY - JOUR AU - Esmaealzadeh N AU - Miri MS AU - Mavaddat H AU - Peyrovinasab A AU - Ghasemi Zargar S AU - Sirous Kabiri S AU - Razavi SM AU - Abdolghaffari AH TI - The Regulating Effect of Curcumin on Nf-Κb Pathway in Neurodegenerative Diseases: A Review of the Underlying Mechanisms JO - Inflammopharmacology VL - 32 IS - 4 SP - 2125 EP - 2151 PY - 2024 ER - |